These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33303407)

  • 1. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
    Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
    J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.
    Forsberg L; Navér L; Gustafsson LL; Wide K
    PLoS One; 2014; 9(11):e111327. PubMed ID: 25365553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.
    Klinger G; Frankenthal D; Merlob P; Diamond G; Sirota L; Levinson-Castiel R; Linder N; Stahl B; Inbar D
    J Perinatol; 2011 Sep; 31(9):615-20. PubMed ID: 21311497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
    J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSRI treatment during pregnancy: are we asking the right questions?
    Wisner KL
    Depress Anxiety; 2010 Aug; 27(8):695-8. PubMed ID: 20694964
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
    Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
    Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
    Nordeng H; Lindemann R; Perminov KV; Reikvam A
    Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.
    Klinger G; Merlob P
    Isr J Psychiatry Relat Sci; 2008; 45(2):107-13. PubMed ID: 18982836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects.
    Ornoy A; Koren G
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):247-259. PubMed ID: 29345153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study.
    Pogliani L; Falvella FS; Cattaneo D; Pileri P; Moscatiello AF; Cheli S; Baldelli S; Fabiano V; Cetin I; Clementi E; Zuccotti G
    Ther Drug Monit; 2017 Apr; 39(2):197-201. PubMed ID: 28045861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.
    Gastaldon C; Arzenton E; Raschi E; Spigset O; Papola D; Ostuzzi G; Moretti U; Trifirò G; Barbui C; Schoretsanitis G
    Psychol Med; 2023 Sep; 53(12):5645-5653. PubMed ID: 36128628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
    JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
    Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.